Study Details
Post-marketing study of gabapentin enacarbil to evaluate the effect in restless leg syndrome (RLS) patients with moderate renal impairment
Clinicaltrials.gov ID
Astellas Study ID
8825-CL-0103
EudraCT ID
N/A
Condition
Restless Legs Syndrome
Phase
Phase 4
Age
20 years - 80 years
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
Nov 2013 - May 2015
Masking
None (Open Label)
Enrollment number
19
Post-marketing clinical study of gabapentin enacarbil ―Non-blinded study in restless legs syndrome (RLS) patients with moderate renal impairment―
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for Post-marketing study of gabapentin enacarbil to evaluate the effect in restless leg syndrome (RLS) patients with moderate renal impairment? Contact us by filling our your information to the right and we’ll respond to you.